These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3049017)

  • 61. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation.
    Qasqas SA; McPherson C; Frishman WH; Elkayam U
    Cardiol Rev; 2004; 12(4):201-21. PubMed ID: 15191632
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drugs in pregnancy. Adverse reactions.
    Ellis C; Fidler J
    Br J Hosp Med; 1982 Dec; 28(6):575-84. PubMed ID: 7150837
    [No Abstract]   [Full Text] [Related]  

  • 63. Inhibitors of prostaglandin synthesis during pregnancy. 1. Embryopathic activity of indomethacin in mice.
    Persaud TV; Moore KL
    Anat Anz; 1974; 136(4):349-53. PubMed ID: 4460761
    [No Abstract]   [Full Text] [Related]  

  • 64. Opioid receptor approaches for the development of medications for pregnant women.
    Szeto HH
    NIDA Res Monogr; 1995; 149():100-15. PubMed ID: 8775837
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical aspects of developmental pharmacology and toxicology.
    Aranda JV; Stern L
    Pharmacol Ther; 1983; 20(1):1-51. PubMed ID: 6353435
    [No Abstract]   [Full Text] [Related]  

  • 66. Materno-fetal cholinesterase inhibitor poisoning.
    Weis OF; Müller FO; Lyell H; Badenhorst CH; van Niekerk P
    Anesth Analg; 1983 Feb; 62(2):233-5. PubMed ID: 6829926
    [No Abstract]   [Full Text] [Related]  

  • 67. [Experimental study of cardiotoxic effect of the pesticide sulfocarbathione].
    Gadalina ID; Mikhaĭlova OG; Vendilo MV
    Gig Sanit; 1990 Nov; (11):35-8. PubMed ID: 2093584
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Placental transfer of drugs.
    Chamberlain G
    Clin Exp Obstet Gynecol; 1986; 13(3-4):107-12. PubMed ID: 3536179
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effects of maternal methadone addiction on the growth and health of the fetus].
    Rosati P; De Santis M; Noia G; Bellati U; Mancuso S
    Minerva Ginecol; 1988 Oct; 40(10):597-601. PubMed ID: 3222002
    [No Abstract]   [Full Text] [Related]  

  • 70. Physiological changes during pregnancy and their implications for pharmacological treatment.
    Redmond GP
    Clin Invest Med; 1985; 8(4):317-22. PubMed ID: 4075616
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Maternal drug exposure and perinatal intracranial hemorrhage.
    Soller RW; Stander H
    Obstet Gynecol; 1981 Dec; 58(6):735-40. PubMed ID: 7312240
    [No Abstract]   [Full Text] [Related]  

  • 72. [Characteristics of the examination and drug therapy of pregnant women suffering from cardiovascular diseases].
    Eliseev OM
    Ter Arkh; 1988; 60(10):33-7. PubMed ID: 3222746
    [No Abstract]   [Full Text] [Related]  

  • 73. Editorial: Noxious transplacental influences.
    Lancet; 1974 Jun; 1(7869):1267. PubMed ID: 4134152
    [No Abstract]   [Full Text] [Related]  

  • 74. THE EFFECTS ON THE FETUS OF DRUGS GIVEN DURING PREGNANCY.
    MEESTER WD
    Marquette Med Rev; 1964 Nov; 30():147-54. PubMed ID: 14227526
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacological treatment of the fetus. Clinical pharmacokinetic considerations.
    Ward RM
    Clin Pharmacokinet; 1995 May; 28(5):343-50. PubMed ID: 7614774
    [No Abstract]   [Full Text] [Related]  

  • 76. Drugs in feto maternal medicine.
    Tambyraja RL
    Ann Acad Med Singap; 1987 Apr; 16(2):281-5. PubMed ID: 3318658
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fetal and perinatal exposure to drugs and chemicals: novel biomarkers of risk.
    Etwel F; Hutson JR; Madadi P; Gareri J; Koren G
    Annu Rev Pharmacol Toxicol; 2014; 54():295-315. PubMed ID: 24160701
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Etretinate embryotoxicity 7 months after discontinuation of treatment.
    Verloes A; Dodinval P; Koulischer L; Lambotte R; Bonnivert J
    Am J Med Genet; 1990 Nov; 37(3):437-8. PubMed ID: 2260582
    [No Abstract]   [Full Text] [Related]  

  • 79. Effect of maternal inhalation of 10 oxygen upon the human fetus.
    Wood C; Hammond J; Lumley J; Newman W
    Aust N Z J Obstet Gynaecol; 1971 May; 11(2):85-90. PubMed ID: 5284377
    [No Abstract]   [Full Text] [Related]  

  • 80. Exposure to chemical carcinogens during pregnancy: consequences for mother and conceptus.
    Rice JM
    Adv Exp Med Biol; 1984; 176():13-49. PubMed ID: 6388255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.